Your browser doesn't support javascript.
loading
Incidence and Management of Diarrhea With Adjuvant Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
Bines, José; Procter, Marion; Restuccia, Eleonora; Viale, Giuseppe; Zardavas, Dimitrios; Suter, Thomas; Arahmani, Amal; Van Dooren, Veerle; Baselga, José; Clark, Emma; Eng-Wong, Jennifer; Gelber, Richard D; Piccart, Martine; Mobus, Volker; de Azambuja, Evandro.
Afiliação
  • Bines J; Instituto Nacional de Câncer and Clínica São Vicente, Rio de Janeiro, Brazil. Electronic address: jose_bines@yahoo.com.
  • Procter M; Frontier Science, Kincraig, United Kingdom.
  • Restuccia E; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Viale G; University of Milan and European Institute of Oncology, Scientific Institute for Research, Hospitalization, and Healthcare, Milan, Italy.
  • Zardavas D; The Breast International Group, Brussels, Belgium; Bristol-Myers Squibb, Princeton, NJ.
  • Suter T; Roche Pharma, Bern, Switzerland.
  • Arahmani A; The Breast International Group, Brussels, Belgium.
  • Van Dooren V; Breast European Adjuvant Study Team Data Center, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Baselga J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Clark E; Roche Products, Welwyn Garden City, United Kingdom.
  • Eng-Wong J; Genentech, South San Francisco, CA.
  • Gelber RD; Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA; Harvard T.H. Chan School of Public Health, Boston, MA; Frontier Science and Technology Research Foundation, Boston, MA.
  • Piccart M; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Mobus V; Clinical Center Frankfurt Höchst, Frankfurt, Germany.
  • de Azambuja E; Breast European Adjuvant Study Team Data Center, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
Clin Breast Cancer ; 20(2): 174-181.e3, 2020 04.
Article em En | MEDLINE | ID: mdl-31924513

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 3_ND / 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Diarreia / Anticorpos Monoclonais Humanizados / Trastuzumab Tipo de estudo: Clinical_trials / Diagnostic_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Clin Breast Cancer Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 3_ND / 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Diarreia / Anticorpos Monoclonais Humanizados / Trastuzumab Tipo de estudo: Clinical_trials / Diagnostic_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Clin Breast Cancer Ano de publicação: 2020 Tipo de documento: Article